Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA) - 15/01/16
Doi : 10.1016/j.jaad.2015.09.073
John E. Harris, MD, PhD a, ⁎ 
, Mehdi Rashighi, MD a, Nhan Nguyen, MD b, Ali Jabbari, MD, PhD b, Grace Ulerio, BA b, Raphael Clynes, MD, PhD b, Angela M. Christiano, PhD b, c, Julian Mackay-Wiggan, MD, MS b, ⁎
, Mehdi Rashighi, MD a, Nhan Nguyen, MD b, Ali Jabbari, MD, PhD b, Grace Ulerio, BA b, Raphael Clynes, MD, PhD b, Angela M. Christiano, PhD b, c, Julian Mackay-Wiggan, MD, MS b, ⁎ a Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts
b Department of Dermatology, Columbia University, New York, NY
c Department of Genetics, Columbia University, New York, NY
∗Correspondence to: John E. Harris, MD, PhD, Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, 364 Plantation St, Worcester, MA 01605Division of DermatologyDepartmentof MedicineUniversity of Massachusetts Medical School 364 Plantation StWorcesterMA01605∗∗Julian Mackay-Wiggan, MD, MS, Department of Dermatology, Columbia University, 161 Fort Washington Ave, 12th Floor, New York, NY 10032Department of DermatologyColumbia University161 Fort Washington Ave12th FloorNew YorkNY10032
| Supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, R21AR061881 (Drs Christiano and Clynes), U01AR067173 (Dr Christiano), and P30AR044535 (the Columbia University Skin Disease Research Center); a research grant from the Vitiligo Research Foundation, VRF05232014/1; Kawaja Family Vitiligo Research Initiative Award; Dermatology Foundation Stiefel Scholar Award (Dr Harris); Physician-Scientist Career Development Award from the Dermatology Foundation; Louis V. Gerstner Jr Scholars Program; Irving Scholars Program from the Irving Institute for Clinical and Translational Research/Columbia University Medical Center (Dr Jabbari); Locks of Love Foundation; and the Alopecia Areata Initiative. |
|
| Conflicts of interest: None declared. |
© 2015
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 74 - N° 2
P. 370-371 - février 2016 Retour au numéro
Article précédent
- Thalidomide for the treatment of chronic refractory pruritus
- Divya Sharma, Shawn G. Kwatra
- A systematic review of pulse steroid therapy for alopecia areata
- Rony Shreberk-Hassidim, Yuval Ramot, Zvi Gilula, Abraham Zlotogorski
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?